AbbVie at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
AbbVie brings 13 presentations to SCOPE 2027 in Orlando. Its sessions cover AI in trial design, study start-up and statistical analysis, along with digital measures and the patient voice. A distinctive item is DECODE, a precompetitive collaboration on biomarkers and endpoints for obesity and nocturnal scratch.
| Organization | SCOPE 2027 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Global pharmaceutical company with medicines in immunology, oncology, neuroscience and eye care. | Panel Mon Mar 1 5:04pm–5:40pm KEYNOTE INTERACTIVE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research Patient recruitment and engagement Talk Tue Mar 2 11:05am–11:30am Turning Insights into Impact: Harnessing Employee Lived Experience to Advance Mental Health Research Patient recruitment and engagement Talk Tue Mar 2 3:05pm–3:30pm Talk Tue Mar 2 3:05pm–3:30pm Talk Tue Mar 2 3:05pm–3:30pm Panel Tue Mar 2 4:45pm–5:10pm Talk Wed Mar 3 9:20am–9:35am Talk Wed Mar 3 11:40am–12:00pm Talk Wed Mar 3 12:00pm–12:17pm Panel Wed Mar 3 12:05pm–12:30pm Talk Wed Mar 3 3:25pm–3:50pm Talk Thu Mar 4 8:35am–9:00am Reimagining Statistical Analysis in Drug Development: From a Standardized, Reproducible Analytical Solution to AI-Assisted Clinical Decision Workflow AI in clinical researchClinical data and real-world evidence Panel Thu Mar 4 9:25am–9:50am Driving Clinical Trial Efficiency with Digital Measures Digital measures and eClinical technology |
Instantly find 20 buyers from AbbVie
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction